Palatin Technologies
PTN
#10775
Rank
C$27.1 M
Marketcap
C$15.23
Share price
-18.11%
Change (1 day)
N/A
Change (1 year)

P/S ratio for Palatin Technologies (PTN)

P/S ratio as of September 2026 (TTM): 1.51

According to Palatin Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.84. At the end of 2026 the company had a P/S ratio of 2.75.

P/S ratio history for Palatin Technologies from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.75-9.81%
20253.05-95.9%
202474.4865.71%
20237.70-16.22%
20229.19-94.21%
2021159
2020N/A-100%
20192.97-38.88%
20184.86144.49%
20171.99
2016N/A
2015N/A-100%
20142.34
2013N/A-100%
2012515838.95%
201154.81439.31%
20103.56103.7%
20091.75-16.33%
20082.0989.45%
20071.10-85.8%
20067.77-25.86%
200510.5-30.77%
200415.1-66.18%
200344.7-15.9%
200253.2-69.07%
2001172

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.68 342.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.15 174.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
4.92 225.35%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
167 10,930.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
20.1 1,231.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
1.79 18.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
2.05 35.86%๐Ÿ‡บ๐Ÿ‡ธ USA